Before considering peptide therapy, patients undergo a detailed medical evaluation, including review of medical history, current medications, and appropriate laboratory testing
Physical degradation: aggregation and precipitation Beyond chemical changes, tirzepatide can undergo physical degradation that alters its structure without breaking covalent bonds
Mechanism of Action: Dual Receptor Targeting Cagrilintide operates through a sophisticated dual receptor mechanism, functioning as both an amylin receptor agonist (targeting AMY1R, AMY2R, and AMY3R) and a calcitonin receptor (CTR) agonist
In some embodiments, the otoprotectant is a compound of Formula (XI) having the structure of Formula (XIa): In some embodiments, the otoprotectant is any one of the following compounds: or a pharmaceutically acceptable salt, pharmaceutically acceptable solvate or hydrate, pharmaceutically acceptable salt hydrate, or pharmaceutically acceptable prodrug thereof